首页> 外文期刊>Diabetes >Transferability and Fine Mapping of Type 2 Diabetes Loci in African Americans: The Candidate Gene Association Resource Plus Study
【24h】

Transferability and Fine Mapping of Type 2 Diabetes Loci in African Americans: The Candidate Gene Association Resource Plus Study

机译:非洲裔美国人2型糖尿病基因座的可移植性和精细定位:候选基因协会资源加研究

获取原文
获取原文并翻译 | 示例
       

摘要

Type 2 diabetes (T2D) disproportionally affects African Americans (AfA) but, to date, genetic variants identified from genome-wide association studies (GWAS) are primarily from European and Asian populations. We examined the single nucleotide polymorphism (SNP) and locus transferability of 40 reported T2D loci in six AfA GWAS consisting of 2,806 T2D case subjects with or without end-stage renal disease and 4,265 control subjects from the Candidate Gene Association Resource Plus Study. Our results revealed that seven index SNPs at the TCF7L2, KLF14, KCNQ1, ADCY5, CDKAL1, JAZF1, and GCKR loci were significantly associated with T2D (P < 0.05). The strongest association was observed at TCF7L2 rs7903146 (odds ratio [OR] 1.30;P = 6.86 × 10~(-8). Locus-wide analysis demonstrated significant associations (P_(emp) < 0.05) at regional best SNPs in the TCF7L2, KLF14, and HMGA2 loci as well as suggestive signals in KCNQ1 after correction for the effective number of SNPs at each locus. Of these loci, the regional best SNPs were in differential linkage disequilibrium (LD) with the index and adjacent SNPs. Our findings suggest that some loci discovered in prior reports affect T2D susceptibility in AfA with similar effect sizes. The reduced and differential LD pattern in AfA compared with European and Asian populations may facilitate fine mapping of causal variants at loci shared across populations.
机译:2型糖尿病(T2D)对非裔美国人(AfA)的影响不成比例,但迄今为止,从全基因组关联研究(GWAS)中识别出的遗传变异主要来自欧洲和亚洲人群。我们检查了6个AfA GWAS中40个报告的T2D基因座的单核苷酸多态性(SNP)和基因座转移性,这些AfA GWAS由2806名患有或不患有终末期肾脏疾病的T2D病例受试者和4,265名来自候选基因协会资源加研究的对照受试者组成。我们的结果表明,TCF7L2,KLF14,KCNQ1,ADCY5,CDKAL1,JAZF1和GCKR位点的七个索引SNP与T2D显着相关(P <0.05)。在TCF7L2 rs7903146处观察到最强的关联(奇数比[OR] 1.30; P = 6.86×10〜(-8)。在全基因座分析中,在TCF7L2中区域最佳SNP处存在显着的关联(P_(emp)<0.05),校正每个位点的有效SNP数后,KCNQ1中的KLF14和HMGA2位点以及提示信号,在这些位点中,区域最佳SNP位于具有索引和相邻SNP的微分连锁不平衡(LD)中。在先前的报告中发现的一些基因座会影响AfA中的T2D易感性,且具有相似的效应大小;与欧洲和亚洲人群相比,AfA中LD模式的减少和差异可能有助于精细绘制各个人群共享的基因座上的因果变异。

著录项

  • 来源
    《Diabetes》 |2013年第3期|965-976|共12页
  • 作者单位

    Center for Genomics and Personalized Medicine Research Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, North Carolina;

    Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts;

    Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, North Carolina;

    Center for Genomics and Personalized Medicine Research Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, North Carolina Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina;

    Center for Genomics and Personalized Medicine Research;

    Research Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, North Carolina;

    Department of Preventive Medicine, Northwestern University, Chicago, Illinois;

    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania;

    Cardiovascular Health Research Unit, Departments of Medicine and Epidemiology, University of Washington, Seattle, Washington;

    Division of Sleep Medicine, Brigham and Women's Hospital, Boston, Massachusetts;

    Center for Healthy Communities, University of South Alabama College of Medicine, Mobile, Alabama;

    School of Medicine, University of Mississippi Medical Center, Jackson, Mississippi;

    Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California;

    Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina;

    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania;

    Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;

    Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts;

    General Medicine Division, Massachusetts General Hospital, Boston, Massachusetts Department of Medicine, Harvard Medical School, Boston, Massachusetts;

    Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle, Washington;

    Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota;

    Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina;

    Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina;

    Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California;

    Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi;

    Center for Genomics and Personalized Medicine Research Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, North Carolina Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:23

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号